These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 16112644
1. Effects of SUMO-1 upon Epstein-Barr virus BZLF1 function and BMRF1 expression. Adamson AL. Biochem Biophys Res Commun; 2005 Oct 14; 336(1):22-8. PubMed ID: 16112644 [Abstract] [Full Text] [Related]
2. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Adamson AL, Kenney SC. Virology; 1998 Nov 10; 251(1):187-97. PubMed ID: 9813214 [Abstract] [Full Text] [Related]
3. The Epstein-Barr virus (EBV) DNA polymerase accessory protein, BMRF1, activates the essential downstream component of the EBV oriLyt. Zhang Q, Holley-Guthrie E, Ge JQ, Dorsky D, Kenney S. Virology; 1997 Mar 31; 230(1):22-34. PubMed ID: 9126259 [Abstract] [Full Text] [Related]
4. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S. J Virol; 1996 Aug 31; 70(8):5131-42. PubMed ID: 8764021 [Abstract] [Full Text] [Related]
5. Low level of lytic replication in a recombinant Epstein-Barr virus carrying an origin of replication devoid of BZLF1-binding sites. Feederle R, Delecluse HJ. J Virol; 2004 Nov 31; 78(21):12082-4. PubMed ID: 15479851 [Abstract] [Full Text] [Related]
6. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation. Hong Y, Holley-Guthrie E, Kenney S. Virology; 1997 Mar 03; 229(1):36-48. PubMed ID: 9123876 [Abstract] [Full Text] [Related]
7. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. Adamson AL, Kenney S. J Virol; 2001 Mar 03; 75(5):2388-99. PubMed ID: 11160742 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. LaJeunesse DR, Brooks K, Adamson AL. Biochem Biophys Res Commun; 2005 Jul 29; 333(2):438-42. PubMed ID: 15950179 [Abstract] [Full Text] [Related]
9. Architecture of replication compartments formed during Epstein-Barr virus lytic replication. Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Shirata N, Tsurumi T. J Virol; 2005 Mar 29; 79(6):3409-18. PubMed ID: 15731235 [Abstract] [Full Text] [Related]
10. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. Chang Y, Lee HH, Chen YT, Lu J, Wu SY, Chen CW, Takada K, Tsai CH. J Virol; 2006 Aug 29; 80(15):7748-55. PubMed ID: 16840354 [Abstract] [Full Text] [Related]
11. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S. J Virol; 2004 Apr 29; 78(8):4197-206. PubMed ID: 15047835 [Abstract] [Full Text] [Related]
12. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. Bhaduri-McIntosh S, Landry ML, Nikiforow S, Rotenberg M, El-Guindy A, Miller G. J Infect Dis; 2007 Feb 15; 195(4):483-92. PubMed ID: 17230407 [Abstract] [Full Text] [Related]
13. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer. Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF. Clin Cancer Res; 2008 Feb 15; 14(4):984-94. PubMed ID: 18281530 [Abstract] [Full Text] [Related]
14. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Petosa C, Morand P, Baudin F, Moulin M, Artero JB, Müller CW. Mol Cell; 2006 Feb 17; 21(4):565-72. PubMed ID: 16483937 [Abstract] [Full Text] [Related]
15. The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD. Salamun SG, Sitz J, De La Cruz-Herrera CF, Yockteng-Melgar J, Marcon E, Greenblatt J, Fradet-Turcotte A, Frappier L. J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462557 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein. Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T. J Biol Chem; 2009 Aug 07; 284(32):21557-68. PubMed ID: 19491105 [Abstract] [Full Text] [Related]
17. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Tian S, Poukka H, Palvimo JJ, Jänne OA. Biochem J; 2002 Nov 01; 367(Pt 3):907-11. PubMed ID: 12144530 [Abstract] [Full Text] [Related]
18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH, Wolf H, Minarovits J. Autoimmunity; 2008 May 01; 41(4):298-328. PubMed ID: 18432410 [Abstract] [Full Text] [Related]
19. A molecular link between malaria and Epstein-Barr virus reactivation. Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT. PLoS Pathog; 2007 Jun 01; 3(6):e80. PubMed ID: 17559303 [Abstract] [Full Text] [Related]
20. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription. Kusano S, Ikeda M. J Biol Chem; 2019 Oct 11; 294(41):15104-15116. PubMed ID: 31434743 [Abstract] [Full Text] [Related] Page: [Next] [New Search]